CINDY MARSHALL: Open Payments
NPI 1538199682 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$50,822 in 86 payments from 6 companies in 2025. Trend: 2023 $10,903 · 2024 $65,015 · 2025 $50,822
Consulting: $24,190Speaker / faculty: $22,790Travel & lodging: $2,494Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 61 | $27,038 |
| Lilly USA, LLC | 20 | $19,364 |
| Eli Lilly and Company | 1 | $4,300 |
| Otsuka America Pharmaceutical, Inc. | 1 | $50 |
| GE HEALTHCARE | 2 | $44 |
| C2N Diagnostics, LLC | 1 | $26 |
Products named: Leqembi, AMYVID, KISUNLA, REXULTI, PRECIVITYAD2.
Industry payments across TX — which companies pay providers there.
